Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common

Hartmut Jaeschke1, Olamide B Adelusi1, Jephte Y Akakpo1

  • 1Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.

Keywords:
AIF, apoptosis-inducing factorAMPK, AMP-activated protein kinaseAPAP, acetaminophenARE, antioxidant response elementATG, autophagy-related genesAcetaminophen hepatotoxicityApoptosisAutophagyBSO, buthionine sulfoximineCAD, caspase-activated DNaseCYP, cytochrome P450 enzymesDAMPs, damage-associated molecular patternsDMSO, dimethylsulfoxideDrug metabolismEndoG, endonuclease GFSP1, ferroptosis suppressing protein 1FerroptosisGPX4, glutathione peroxidase 4GSH, glutathioneGSSG, glutathione disulfideGclc, glutamate–cysteine ligase catalytic subunitGclm, glutamate–cysteine ligase modifier subunitHMGB1, high mobility group box protein 1HNE, 4-hydroxynonenalInnate immunityJNK, c-jun N-terminal kinaseKEAP1, Kelch-like ECH-associated protein 1LAMP, lysosomal-associated membrane proteinLC3, light chain 3LOOH, lipid hydroperoxidesLPO, lipid peroxidationMAP kinase, mitogen activated protein kinaseMCP-1, monocyte chemoattractant protein-1MDA, malondialdehydeMPT, mitochondrial permeability transitionMitochondriaMnSOD, manganese superoxide dismutaseNAC, N-acetylcysteineNAPQI, N-acetyl-p-benzoquinone imineNF-κB, nuclear factor κBNQO1, NAD(P)H:quinone oxidoreductase 1NRF2NRF2, nuclear factor erythroid 2-related factor 2PUFAs, polyunsaturated fatty acidsROS, reactive oxygen speciesSMAC/DIABLO, second mitochondria-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pITLR, toll like receptorTUNEL, terminal deoxynucleotidyl transferase dUTP nick end labelingUGT, UDP-glucuronosyltransferasesmTORC1, mammalian target of rapamycin complex 1

Related Concept Videos

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
191
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
105
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
10
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
167
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
247
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
445